The single IGF-1 partial deficiency is responsible for mitochondrial dysfunction and is restored by IGF-1 replacement...

Area of Science:

• Biochemistry
• Cell Biology
• Mitochondrial Medicine

Background:

• Hepatic mitochondrial dysfunction and oxidative damage are observed in conditions of insulin-like growth factor-1 (IGF-1) deficiency, such as cirrhosis and aging.
• Low doses of IGF-1 were previously shown to improve hepatic mitochondrial function in these conditions.
• This study investigates whether partial IGF-1 deficiency alone, without other insults, leads to hepatic mitochondrial dysfunction.

Purpose of the Study:

• To determine if partial insulin-like growth factor-1 (IGF-1) deficiency is sufficient to cause hepatic mitochondrial dysfunction.
• To assess the therapeutic effect of IGF-1 replacement on mitochondrial function in the context of partial IGF-1 deficiency.

Main Methods:

• Utilized heterozygous (igf1+/-) mice, with and without IGF-1 treatment, alongside a wild-type control group.
• Assessed hepatic mitochondrial function using flow cytometry (membrane potential, free radicals, proton leak) and spectrophotometry (ATPase activity).
• Analyzed antioxidant enzyme activities, electron transport chain enzyme levels, and gene expression related to mitochondrial protection and apoptosis via RT-qPCR and microarray analysis.

Main Results:

• Heterozygous mice exhibited reduced mitochondrial membrane potential and ATPase activity, with increased free radical production and proton leak.
• IGF-1 replacement therapy normalized these mitochondrial parameters in heterozygous mice.
• Gene expression related to mitochondrial protection and apoptosis was altered in deficient mice but restored with IGF-1 treatment.

Conclusions:

• Partial insulin-like growth factor-1 (IGF-1) deficiency is intrinsically linked to hepatic mitochondrial dysfunction.
• IGF-1 plays a protective role in the liver by mitigating free radical production, oxidative damage, and apoptosis.
• IGF-1 exerts these protective effects through the regulation of gene expression for cytoprotective and antiapoptotic proteins.